account_id none on file
legal_name Nanobiotix S.A.
ticker NBTX
cik 1760854
domain nanobiotix.com
linkedin_company_url https://www.linkedin.com/company/nanobiotix
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 5 executives 0 family 0
why_nownone on file
callsnone on file
filings
▪ making recommendations to the Supervisory Board regarding compensation, including equity-based compensation and expense reimbursement, for the members of the Supervisory Board, taking into account corporate goals and objectives and performance of Supervisory Board members in light of such goals and objectives;
filing / Mar 31, 2026 / receipt
Any cost containment measures could significantly decrease the available coverage and the price we might establish for our potential products, which would have an adverse effect on our net revenues and operating results.
filing / Mar 31, 2026 / receipt
Cost containment measures that healthcare payors and providers are instituting and the effect of further healthcare reform could significantly reduce potential revenues from the sale of any of our product candidates approved in the future, and could cause an increase in our compliance, manufacturing, or other operating expenses.
filing / Mar 31, 2026 / receipt
Our corporate headquarters is located in Paris, France, where we lease approximately 2,622 square meters of office space.
filing / Mar 31, 2026 / receipt
We also rent office space for Nanobiotix Corp., our wholly owned U.S. subsidiary, in Cambridge, Massachusetts on a month-to-month basis.
filing / Mar 31, 2026 / receipt
executivesnone on file
familynone on file
upcomingnone on file
changesnone on file
mcp_package_hint
slug nanobiotix-s-a
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$